Echolase, a young startup with a product that crosses over between technology and life sciences, is on the brink of getting its first outside funding from a local investment group.
But with the future of the company dependent on getting more money—Echolase needs funds to further test its medical imaging device, to rent office space, and to hire employees—the founders are eyeing public funds, too, such as the few billion dollars in federal money awarded to startups through from Small Business Innovation Research and Small Business Technology Transfer grants. Randolph Glickman, Echolase’s chief technology officer, was at a meeting hosted by the University of Texas at San Antonio last week designed to help researchers like him learn how to most effectively apply for and earn federal money.
Xconomy Texas-San Antonio-September 13, 2016